Literature DB >> 3030986

The inhibition of neoplastic cell proliferation with human natural tumor necrosis factor.

M Nobuhara, T Kanamori, Y Ashida, H Ogino, Y Horisawa, K Nakayama, T Asami, M Iketani, K Noda, S Andoh.   

Abstract

Purified human natural tumor necrosis factor (n-TNF) was prepared by stimulating human leukemic B cell line (BALL-1) with Sendai virus. The colony formations of all of 18 human cancer-derived abnormal cell lines were suppressed by 10(1)-10(6) U/ml of n-TNF, while n-TNF was nontoxic to all human normal fibroblast cells. This in vitro inhibition of cell growth was reversible. In breast adenocarcinoma MCF7 cells treated with n-TNF a specific decrease of DNA synthesis was observed, and DNA histograms showed a block at G1 in the cell cycle. In vivo studies revealed that n-TNF suppressed the tumor growth of murine Meth A sarcoma, human renal adenocarcinoma (ACHN), malignant melanoma (SK-MEL-28) and glioblastoma (U-373 MG). Isobologram analysis showed that n-TNF synergistically inhibited cell growth in combination with human natural interferon (IFN)-a. In vivo synergism of n-TNF and IFN-a was also found in the U-373 MG tumor model implanted into nude mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3030986

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  10 in total

1.  Absence of tumor necrosis factor-alpha in suction blister fluids and stratum corneum from patients with psoriasis.

Authors:  H Takematsu; H Ohta; H Tagami
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

2.  Effects of natural interferon alpha, natural tumor necrosis factor alpha and their combination on human mesothelioma xenografts in nude mice.

Authors:  T Ohnuma; L Szrajer; J F Holland; M Kurimoto; J Minowada
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

3.  Cellular and cytokine responses of the human central nervous system to intracranial administration of tumor necrosis factor alpha for the treatment of malignant gliomas.

Authors:  M Tada; Y Sawamura; S Sakuma; K Suzuki; H Ohta; T Aida; H Abe
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

4.  In vivo anti-tumor efficacy of polyethylene glycol-modified tumor necrosis factor-alpha against tumor necrosis factor-resistant tumors.

Authors:  Y Tsutsumi; S Tsunoda; Y Kaneda; H Kamada; T Kihira; S Nakagawa; Y Yamamoto; Y Horisawa; T Mayumi
Journal:  Jpn J Cancer Res       Date:  1996-10

5.  Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potency.

Authors:  Y Tsutsumi; T Kihira; S Tsunoda; T Kanamori; S Nakagawa; T Mayumi
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

6.  Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency.

Authors:  Y Tsutsumi; S Tsunoda; H Kamada; T Kihira; S Nakagawa; Y Kaneda; T Kanamori; T Mayumi
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

7.  Intravenous administration of polyethylene glycol-modified tumor necrosis factor-alpha completely regressed solid tumor in Meth-A murine sarcoma model.

Authors:  Y Tsutsumi; T Kihira; S Tsunoda; K Kubo; M Miyake; T Kanamori; S Nakagawa; T Mayumi
Journal:  Jpn J Cancer Res       Date:  1994-12

8.  In vivo antitumor mechanism of natural human tumor necrosis factor involving a T cell-mediated immunological route.

Authors:  T Asami; M Imai; Y Tanaka; Y Hosaka; K Kato; N Nakamura; Y Horisawa; Y Ashida; T Kanamori; M Nobuhara
Journal:  Jpn J Cancer Res       Date:  1989-12

9.  Chemical modification of natural human tumor necrosis factor-alpha with polyethylene glycol increases its anti-tumor potency.

Authors:  Y Tsutsumi; T Kihira; S Yamamoto; K Kubo; S Nakagawa; M Miyake; Y Horisawa; T Kanamori; H Ikegami; T Mayumi
Journal:  Jpn J Cancer Res       Date:  1994-01

Review 10.  Optimization of protein therapies by polymer-conjugation as an effective DDS.

Authors:  Hiroko Shibata; Shinsaku Nakagawa; Yasuo Tsutsumi
Journal:  Molecules       Date:  2005-01-31       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.